Serum Iron Markers Are Inadequate for Guiding Iron Repletion in Chronic Kidney Disease | Zendy

Paolo Ferrari | Zendy; Hemant Kulkarni | Zendy; Shyam Dheda | Zendy; Susanne Betti | Zendy; Colin Harrison | Zendy; Timothy G. St. Pierre | Zendy; John K. Olynyk | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum Iron Markers Are Inadequate for Guiding Iron Repletion in Chronic Kidney Disease

Author(s) -

Paolo Ferrari,

Hemant Kulkarni,

Shyam Dheda,

Susanne Betti,

Colin Harrison,

Timothy G. St. Pierre,

John K. Olynyk

Publication year - 2010

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.04190510

Subject(s) - medicine , kidney disease , iron status , serum iron , disease , chronic disease , iron levels , gastroenterology , physiology , iron deficiency , anemia

Iron (Fe) overload may complicate parenteral Fe therapy used to enhance the efficacy of erythropoietic-stimulating agents in the treatment of anemia of chronic kidney disease. However, serum Fe markers are influenced by inflammation or malignancy and may not accurately reflect the amount of body Fe.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research